Zhang SS, Nagasaka M, Zhu VW, Ou SI, et al. Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC. Lung Cancer 2021;158:126-136.
PMID: 34175504